These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 23316991)

  • 1. Should the target A1C level be less than 7 percent? No: The case for modest glycemic control in patients with type 2 diabetes.
    Barry HC
    Am Fam Physician; 2012 Dec; 86(12):1-2. PubMed ID: 23316991
    [No Abstract]   [Full Text] [Related]  

  • 2. Should the target A1C level be less than 7 percent? Yes: This should be the target for most patients.
    Peterson K
    Am Fam Physician; 2012 Dec; 86(12):1-2. PubMed ID: 23316992
    [No Abstract]   [Full Text] [Related]  

  • 3. [Control of diabetes mellitus].
    Daweke H
    Verh Dtsch Ges Inn Med; 1990; 96():175-82. PubMed ID: 2092437
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical aspects of Insulin Lispro (LY275585)].
    Kuzuya T
    Nihon Rinsho; 1997 Nov; 55 Suppl():298-305. PubMed ID: 9434484
    [No Abstract]   [Full Text] [Related]  

  • 5. Influence of antidepressant use on glycemic control in patients with diabetes mellitus: an open-label comparative study.
    Derijks HJ; Janknegt R; Heerdink ER; De Koning FH; Krekels MM; Looij BJ; Egberts AC
    J Clin Psychopharmacol; 2009 Aug; 29(4):405-8. PubMed ID: 19593191
    [No Abstract]   [Full Text] [Related]  

  • 6. Hemoglobin A1c values and CGM.
    Blevins T
    Diabetes Technol Ther; 2012 Oct; 14(10):971; author reply 972. PubMed ID: 23013204
    [No Abstract]   [Full Text] [Related]  

  • 7. Meta-analysis: efficacy and safety of inhaled insulin therapy in adults with diabetes mellitus.
    Ceglia L; Lau J; Pittas AG
    Ann Intern Med; 2006 Nov; 145(9):665-75. PubMed ID: 17088580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycemic variability in inadequately controlled type 1 diabetes and type 2 diabetes on intensive insulin therapy: a cross-sectional, observational study.
    Greven WL; Beulens JW; Biesma DH; Faiz S; de Valk HW
    Diabetes Technol Ther; 2010 Sep; 12(9):695-9. PubMed ID: 20687867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using new insulin strategies in the outpatient treatment of diabetes: clinical applications.
    DeWitt DE; Dugdale DC
    JAMA; 2003 May; 289(17):2265-9. PubMed ID: 12734138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Simplified Approach Using Rate of Change Arrows to Adjust Insulin With Real-Time Continuous Glucose Monitoring.
    Klonoff DC; Kerr D
    J Diabetes Sci Technol; 2017 Nov; 11(6):1063-1069. PubMed ID: 28884599
    [No Abstract]   [Full Text] [Related]  

  • 11. 5(th) Annual Symposium on Self-Monitoring of Blood Glucose (SMBG) applications and beyond, May 3-5, 2012, Dublin, Ireland.
    Hoey H; Mlinac A; Tran CT; Schlaeger C
    Diabetes Technol Ther; 2012 Dec; 14(12):1155-73. PubMed ID: 23216339
    [No Abstract]   [Full Text] [Related]  

  • 12. [Self monitoring of blood glucose: tool for successful diabetes therapy].
    Hummel M
    MMW Fortschr Med; 2012 Nov; 154(20):65-8. PubMed ID: 23234124
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of short-term iPRO continuous glucose monitoring on hemoglobin A1c levels in clinical practice.
    Pepper GM; Steinsapir J; Reynolds K
    Diabetes Technol Ther; 2012 Aug; 14(8):654-7. PubMed ID: 22690923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved postprandial blood glucose control and reduced nocturnal hypoglycemia during treatment with two novel insulin lispro-protamine formulations, insulin lispro mix25 and insulin lispro mix50. Mix50 Study Group.
    Roach P; Trautmann M; Arora V; Sun B; Anderson JH
    Clin Ther; 1999 Mar; 21(3):523-34. PubMed ID: 10321421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of glycaemic control in patients with diabetes mellitus on insulin therapy.
    Mukherjee JJ; Majumdar S; Ray S
    J Indian Med Assoc; 2013 Nov; 111(11):761-5. PubMed ID: 24968486
    [No Abstract]   [Full Text] [Related]  

  • 16. Glycosylated hemoglobin level and number of oral antidiabetic drugs predict whether or not glycemic target is achieved in insulin-requiring type 2 diabetes.
    Lin SD; Tsai ST; Tu ST; Su CC; Chen JF; Lu CH; Wang CH; Yu NC; Hsu SR; Hsieh MC
    Prim Care Diabetes; 2015 Apr; 9(2):135-41. PubMed ID: 25266893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycated albumin and glycated hemoglobin are influenced differently by endogenous insulin secretion in patients with type 2 diabetes.
    Koga M; Murai J; Saito H; Kasayama S
    Diabetes Care; 2010 Feb; 33(2):270-2. PubMed ID: 19846794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical experiences with Lantus therapy in Swedish routine health care].
    Löndahl M; Nilsson A; Katzman P
    Lakartidningen; 2005 Sep 5-11; 102(36):2503, 2505. PubMed ID: 16196437
    [No Abstract]   [Full Text] [Related]  

  • 19. Improvements in diabetes treatment.
    Zimmerman BR
    Minn Med; 1995 Apr; 78(4):46-8. PubMed ID: 7760785
    [No Abstract]   [Full Text] [Related]  

  • 20. [Diabetes: education more effective than drugs? Those who know more, live longer].
    Meissner T
    MMW Fortschr Med; 2003 May; 145(20):14. PubMed ID: 12822224
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.